Detail page

Knowledge Web

Person

Laura Tagliaferri (1986-)

Kinderärztin

Name	Laura Tagliaferri
Time	1986- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Mailand (Geburtsort) Italien
Gender	weiblich
Academic degree	Dr. med. (an der Medizinischen Fakultät Heidelberg der Ruprecht-Karls-Universität) (2023)
Profession	Kinderärztin (characteristic profession)
Variant	L. Tagliaferri
Related	Klinikum Heidelberg Universität Heidelberg. Medizinische Fakultät
Further information	Fachärztin, Onkologie, Hämatologie, Immunologie und Pneumologie, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg
Record type	Person
GND-Identifier	1111667624
Record ID	1111667624
Involved in show all Etablierung einer neuen Methode für das Neugeborenenscreening auf schwere kombinierte Immundefekte Benefits of a disease management program for sickle cell disease in Germany 2011–2019 : the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome Benefits of a disease management program for sickle cell disease in Germany 2011–2019: the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome Sickle cell disease in Germany: results from a national registry Sickle cell disease in Germany: Results from a national registry A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Laura Tagliaferri (1986-)

Etablierung einer neuen Methode für das Neugeborenenscreening auf schwere kombinierte Immundefekte

Benefits of a disease management program for sickle cell disease in Germany 2011–2019 : the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome

Benefits of a disease management program for sickle cell disease in Germany 2011–2019: the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome

Sickle cell disease in Germany: results from a national registry

Sickle cell disease in Germany: Results from a national registry

A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition